The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Roehl, Anna B ^a   Zoremba, Norbert ^a   Kipp, Markus ^b   Schiefer, Johannes ^a   Goetzenich, Andreas ^a   Bleilevens, Christian ^a   Kuehn Velten, Nikolaus ^c   Tolba, Rene ^a   Rossaint, Rolf ^a   Hein, Marc ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Medizinisches Labor Bremen   (Germany)

Author keywords

Cerebral ischaemia; Hypoxia; Levosimendan; Microdialysis

Indexed keywords

GLUCOSE; GLUTAMIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTIC ACID; LEVOSIMENDAN; PYRUVIC ACID; TUMOR NECROSIS FACTOR ALPHA; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BLOOD PRESSURE; BRAIN EDEMA; BRAIN METABOLISM; BRAIN PERFUSION; COMMON CAROTID ARTERY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DRUG EFFECT; ENERGY METABOLISM; GENE EXPRESSION; HEART PROTECTION; MALE; MICRODIALYSIS; NEOCORTEX; NONHUMAN; RAT; TRANSIENT GLOBAL AMNESIA; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; ENERGY METABOLISM; HYDRAZONES; HYPOXIA-ISCHEMIA, BRAIN; MALE; NEUROPROTECTIVE AGENTS; OXYGEN; OXYGEN CONSUMPTION; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84865297677     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-81     Document Type: Article

References (45)

1. Fukuda S, Warner DS. Cerebral protection. Br J Anaesth 2007, 99:10-17. 10.1093/bja/aem140, 17573393.
2. Valtysson J, Persson L, Hillered L. Extracellular ischaemia markers in repeated global ischaemia and secondary hypoxaemia monitored by microdialysis in rat brain. Acta Neurochir (Wien) 1998, 140:387-395.
3. Zoremba N, Homola A, Rossaint R, Sykova E. Brain metabolism and extracellular space diffusion parameters during and after transient global hypoxia in the rat cortex. Exp Neurol 2007, 203:34-41. 10.1016/j.expneurol.2006.07.017, 16956608.
4. Sanders RD, Manning HJ, Robertson NJ, Ma D, Edwards AD, Hagberg H, Maze M. Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term. Anesthesiology 2010, 113:233-249. 10.1097/ALN.0b013e3181dc1b84, 20526192.
5. Zhao Z, Corvera JS, Halkos ME, Kerendi F, Wang N, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.
6. Zhao Z, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006, 70:200-211. 10.1016/j.cardiores.2006.01.024, 16545349.
7. Saver JL. Time is brain-quantified. Stroke 2006, 37:263-266.
8. Bernard S. Hypothermia after cardiac arrest: expanding the therapeutic scope. Crit Care Med 2009, 37:S227-S233. 10.1097/CCM.0b013e3181aa5d0c, 19535951.
9. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 2011, 8(11):619-629. 10.1038/nrcardio.2011.85, 21691310.
10. Gao X, Ren C, Zhao H. Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res 2008, 86:2505-2511. 10.1002/jnr.21703, 18438944.
11. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000, 90:5-11. 10.1097/00000539-200001000-00003, 10624967.
12. Hein M, Roehl AB, Baumert JH, Scherer K, Steendijk P, Rossaint R. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction. Acta Anaesthesiol Scand 2009, 53:941-948. 10.1111/j.1399-6576.2009.01994.x, 19426242.
13. Katircioglu SF, Seren M, Parlar AI, Turan NN, Manavbasi Y, Aydog G, Cicekcioglu F, Tutun U, Ulus AT. Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping. J Card Surg 2008, 23:44-48. 10.1111/j.1540-8191.2007.00486.x, 18290886.
14. Lafci B, Yasa H, Ilhan G, Ortac R, Yilik L, Kestelli M, Goktogan T, Gurbuz A. Protection of the spinal cord from ischemia: comparative effects of levosimendan and iloprost. Eur Surg Res 2008, 41:1-7. 10.1159/000121394, 18354255.
15. Roehl AB, Hein M, Loetscher PD, Rossaint J, Weiss J, Rossaint R, Coburn M. Neuroprotective properties of Levosimendan in an in vitro model of traumatic brain injury. BMC Neurol 2010, 10:97. 10.1186/1471-2377-10-97, 2978146, 20964834.
16. Honisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol 2010, 105:155-167. 10.1007/s00395-009-0064-9, 19842009.
17. Das B, Sarkar C. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model. Vascul Pharmacol 2007, 47:248-256. 10.1016/j.vph.2007.06.008, 17728191.
18. Kopustinskiene DM, Pollesello P, Saris NE. Levosimendan is a mitochondrial K(ATP) channel opener. Eur J Pharmacol 2001, 428:311-314. 10.1016/S0014-2999(01)01350-4, 11689188.
19. Mayanagi K, Gaspar T, Katakam PV, Busija DW. Systemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in rats. Brain Res 2007, 1168:106-111.
20. Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2009, 110:986-995. 10.1097/ALN.0b013e31819dadc7, 2930813, 19352153.
21. Guide for the care and use of laboratory animals Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council 2011, Washington, DC: National Academy Press, 8, Guide for the care and use of laboratory animals.
22. Zoremba N, Homola A, Slais K, Vorisek I, Rossaint R, Lehmenkuhler A, Sykova E. Extracellular diffusion parameters in the rat somatosensory cortex during recovery from transient global ischemia/hypoxia. J Cereb Blood Flow Metab 2008, 28(10):1665-1673. 10.1038/jcbfm.2008.58, 18545260.
23. Dethloff TJ, Knudsen GM, Larsen FS. Cerebral blood flow autoregulation in experimental liver failure. J Cereb Blood Flow Metab 2008, 28:916-926. 10.1038/sj.jcbfm.9600589, 18059432.
24. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J Intern Med 1991, 230:365-373. 10.1111/j.1365-2796.1991.tb00459.x, 1919432.
25. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 1999, 79:763-854.
26. Kulik A, Trapp S, Ballanyi K. Ischemia but not anoxia evokes vesicular and Ca(2+)-independent glutamate release in the dorsal vagal complex in vitro. J Neurophysiol 2000, 83:2905-2915.
27. Kunimatsu T, Asai S, Kanematsu K, Zhao H, Kohno T, Misaki T, Ishikawa K. Transient in vivo membrane depolarization and glutamate release before anoxic depolarization in rat striatum. Brain Res 1999, 831:273-282. 10.1016/S0006-8993(99)01481-X, 10412006.
28. Lasarzik I, Noppens RR, Wolf T, Bauer H, Luh C, Werner C, Engelhard K, Thal SC. Dose-Dependent Influence of Sevoflurane Anesthesia on Neuronal Survival and Cognitive Outcome After Transient Forebrain Ischemia in Sprague-Dawley Rats. Neurocrit Care 2011, 15(3):577-584. 10.1007/s12028-011-9562-3, 21618067.
29. Iqbal S, Baziany A, Gordon S, Wright S, Hussain M, Miyashita H, Shuaib A, Hasan Rajput A. Neuroprotective effect of tiagabine in transient forebrain global ischemia: an in vivo microdialysis, behavioral, and histological study. Brain Res 2002, 946:162-170. 10.1016/S0006-8993(02)02871-8, 12137918.
30. Nakayama R, Yano T, Ushijima K, Abe E, Terasaki H. Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemia. Anesthesiology 2002, 96:705-710. 10.1097/00000542-200203000-00029, 11873048.
31. Choi SK, Lee G, Choi S, Kim YJ, Park H, Park BJ. Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model: real time estimation of glutamate. J Korean Neurosurg Soc 2011, 49:1-7. 10.3340/jkns.2011.49.1.1, 3070888, 21494355.
32. Kang SW, Choi S, Park E, Chae S, Choi S, Jin Joo H, Lee G, Park H. Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. Brain Res 2011, 1371:121-128.
33. Domoki F, Perciaccante JV, Veltkamp R, Bari F, Busija DW. Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs. Stroke 1999, 30:2713-8-2718-9. discussion.
34. Robin E, Simerabet M, Hassoun SM, Adamczyk S, Tavernier B, Vallet B, Bordet R, Lebuffe G. Postconditioning in focal cerebral ischemia: role of the mitochondrial ATP-dependent potassium channel. Brain Res 2011, 1375:137-146.
35. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 2001, 292:1543-1546. 10.1126/science.1059829, 11375491.
36. Grover GJ, Newburger J, Sleph PG, Dzwonczyk S, Taylor SC, Ahmed SZ, Atwal KS. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther 1991, 257:156-162.
37. Antila S, Huuskonen H, Nevalainen T, Kanerva H, Vanninen P, Lehtonen L. Site dependent bioavailability and metabolism of levosimendan in dogs. Eur J Pharm Sci 1999, 9:85-91. 10.1016/S0928-0987(99)00048-2, 10494001.
38. Abo-Ramadan U, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E, Soinne L, Strbian D, Tatlisumak T. Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots. Exp Neurol 2009, 219:328-333. 10.1016/j.expneurol.2009.06.002, 19520075.
39. Koizumi H, Fujisawa H, Suehiro E, Shirao S, Suzuki M. Neuroprotective effects of ebselen following forebrain ischemia: involvement of glutamate and nitric oxide. Neurol Med Chir (Tokyo) 2011, 51:337-343.
40. Munakata H, Okada K, Hasegawa T, Hino Y, Kano H, Matsumori M, Okita Y. Controlled low-flow reperfusion after warm brain ischemia reduces reperfusion injury in canine model. Perfusion 2010, 25:159-168. 10.1177/0267659110370068, 20421252.
41. Bravo MC, Lopez P, Cabanas F, Perez-Rodriguez J, Perez-Fernandez E, Quero J, Pellicer A. Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study. Neonatology 2011, 99:217-223. 10.1159/000314955, 20881438.
42. Cengiz SL, Erdi MF, Tosun M, Atalik E, Avunduk MC, Sonmez FC, Mehmetoglu I, Baysefer A. Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study. Brain Inj 2010, 24:877-885. 10.3109/02699051003789260, 20433288.
43. Lenzser G, Kis B, Bari F, Busija DW. Diazoxide preconditioning attenuates global cerebral ischemia-induced blood-brain barrier permeability. Brain Res 2005, 1051:72-80. 10.1016/j.brainres.2005.05.064, 16004973.
44. Zhu H, Luo W, Wang H. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels. Neuroscience 2008, 157:884-894. 10.1016/j.neuroscience.2008.09.033, 18951957.
45. Denes A, Ferenczi S, Kovacs KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation 2011, 8:164. 10.1186/1742-2094-8-164, 3235982, 22114895.